Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPACT in Advanced Solid Tumors
NCT01827384Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2014
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib, adavosertib, everolimus, trametinib in malignant solid neoplasm, sponsored by National Cancer Institute. Started Jan 2014; status: completed.
02
Drugs
veliparibadavosertibeverolimustrametinib
03
Conditions
malignant solid neoplasm
Beyond the preview
Go deeper on NCT01827384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827384.